Mesas Vaz Carmen, Guembe Mülberger Alba, Torrent Burgas Marc
The Systems Biology of Infection Lab, Department of Biochemistry and Molecular Biology, Biosciences Faculty, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
Crit Rev Microbiol. 2024 Oct 9:1-36. doi: 10.1080/1040841X.2024.2407378.
is a versatile Gram-negative pathogen known for its ability to invade the respiratory tract, particularly in cystic fibrosis patients. This review provides a comprehensive analysis of the multifaceted strategies for colonization, virulence, and immune evasion used by to infect the host. We explore the extensive protein arsenal of , including adhesins, exotoxins, secreted proteases, and type III and VI secretion effectors, detailing their roles in the infective process. We also address the unique challenge of treating diverse lung conditions that provide a natural niche for on the airway surface, with a particular focus in cystic fibrosis. The review also discusses the current limitations in treatment options due to antibiotic resistance and highlights promising future approaches that target host-pathogen protein-protein interactions. These approaches include the development of new antimicrobials, anti-attachment therapies, and quorum-sensing inhibition molecules. In summary, this review aims to provide a holistic understanding of the pathogenesis of in the respiratory system, offering insights into the underlying molecular mechanisms and potential therapeutic interventions.
是一种多功能革兰氏阴性病原体,以其侵入呼吸道的能力而闻名,尤其是在囊性纤维化患者中。本综述全面分析了用于感染宿主的定植、毒力和免疫逃避的多方面策略。我们探讨了丰富的蛋白质库,包括黏附素、外毒素、分泌蛋白酶以及III型和VI型分泌效应器,详细阐述了它们在感染过程中的作用。我们还解决了治疗多种肺部疾病的独特挑战,这些疾病为气道表面的提供了天然生态位,尤其关注囊性纤维化。该综述还讨论了由于抗生素耐药性导致的当前治疗选择的局限性,并强调了针对宿主-病原体蛋白质-蛋白质相互作用的有前景的未来方法。这些方法包括开发新的抗菌药物、抗黏附疗法和群体感应抑制分子。总之,本综述旨在全面了解在呼吸系统中的发病机制,深入了解潜在的分子机制和潜在的治疗干预措施。